扩大的PML核体触发了白血病细胞中冲突的细胞周期信号介导的细胞毒性
Tomohisa Baba1, Soichiro Kumamoto2, Yuta Moriguchi2
1Division of Cancer and Senescence Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan. sergenti@staff.kanazawa-u.ac.jp.
Cell death & disease
|August 2, 2025
概括
冲突的细胞循环信号,包括有菌性ERK信号和CDK4/6抑制,增强PML-核体的形成,诱导急性髓性白血病 (AML) 细胞的细胞毒性,并提高AML小鼠模型的治疗疗效.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 分子瘤学分子瘤学
背景情况:
- 矛盾的是,细胞循环停止可以通过mitogenic信号来促进细胞毒性,但机制尚不清楚.
- PML-核体 (PML-NBs) 是细胞应激反应的关键参与者.
研究的目的:
- 为了研究细胞周期动态和PML-NB形成之间的关系.
- 探索组合的线粒体和细胞循环停止信号对PML-NBs和急性髓性白血病 (AML) 中细胞毒性的影响.
主要方法:
- 在相间停止期间监测PML-NB动态.
- 研究全跨视网红酸 (ATRA) 和CDK4/6抑制剂对PML-NB形成和SUMOylation的协同作用.
- 在AML细胞系中评估细胞毒性,分化和亡.
- 在AML小鼠模型中评估治疗疗效.
主要成果:
- 在间阶段停止期间,PML-NB的数量增加.
- 同时发出mitogenic ERK信号 (通过ATRA) 和细胞循环停止 (通过CDK4/6抑制剂) 通过SUMO协会协同扩大PML-NBs.
- 这种联合信号触发了AML细胞系中强烈的细胞毒性 (分化或亡).
- 组合疗法在AML小鼠模型中显示出显著的治疗疗效,对正常血液形成的影响最小.
结论:
- 冲突的细胞循环信号可以诱导强烈的细胞毒性.
- 通过联合信号来准PML-NB的形成,代表了AML的一个有前途的治疗策略.
- 这种方法为AML治疗提供了一个新的途径,有可能改善临床结果.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Negative Regulator Molecules
36.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.0K
Disorders of Leukocytes
1.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.1K
Mitogens and the Cell Cycle
6.8K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.8K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


